Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An EGFR-TKIs Benefit Non-small Cell Lung Carcinoma Patients Identification Strategy and Treatment Response Using Molecular Imaging

NCT02717221 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT02717221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02717221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An EGFR-TKIs Benefit Non-small Cell Lung Carcinoma Patients Identification Strategy and Treatment Response Using Molecular Imaging
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2014
Completion date
December 31, 2019
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

molecular imaging